CBN, short for cannabinol, is a cannabinoid that forms naturally in marijuana as THC ages and breaks down. It’s not produced directly by the plant in significant amounts. Instead, when cannabis is exposed to air, light, and heat over time, THC gradually oxidizes and converts into CBN. This makes it one of the few cannabinoids you get more of by letting your cannabis sit around rather than using it fresh.
How CBN Forms From THC
Fresh cannabis contains very little CBN, typically less than 1%. In one study tracking cannabinoid changes over time, fresh cannabis resin contained about 0.87% CBN alongside 35% THC. After two years of storage, THC dropped to roughly 2.7% while CBN rose to nearly 7%. The conversion happens faster in acidic conditions and at higher temperatures, but it occurs to some degree whenever cannabis is stored in anything less than airtight, light-proof conditions.
The chemical pathway is straightforward: CBD in the plant first converts to THC through a cyclization reaction, and then THC oxidizes into CBN when exposed to air. So CBN is essentially a degradation product. If you’ve ever found old cannabis that lost its potency, a significant portion of its THC likely became CBN.
How CBN Affects Your Body
CBN interacts with the same cannabinoid receptors (CB1 and CB2) that THC does, but with far less strength. Its binding affinity to the CB1 receptor, the one primarily responsible for the “high” from THC, is around 308 nanomolar compared to the low single digits for potent synthetic cannabinoids. In practical terms, CBN’s intoxicating effect is roughly one-quarter the strength of THC’s. You’d notice a mild psychoactive effect at high enough doses, but it won’t produce the same intensity as THC.
CBN binds somewhat more readily to the CB2 receptor, which is more involved in immune function and inflammation. This dual but weak receptor activity is part of why researchers have explored CBN for therapeutic effects that don’t depend on getting you high.
The Sleep Reputation: Stronger Than the Evidence
CBN is widely marketed as a natural sleep aid, and you’ll find it in dozens of gummies and tinctures sold specifically for that purpose. The actual clinical evidence, however, is thin. A 2021 review titled “Cannabinol and Sleep: Separating Fact from Fiction” found no published clinical trials investigating CBN’s effect on sleep using validated sleep questionnaires or formal sleep monitoring. In one of the few controlled studies that looked at CBN’s subjective effects, participants reported feeling drowsy under THC’s influence but not under CBN alone.
Where the sleep connection gets more nuanced is in combination with THC. The effect of cannabinoids on sleep appears to be heavily influenced by which cannabinoids are used together and at what doses. Some early clinical trials are now testing specific combinations of CBN, THC, and CBD for chronic insomnia, but results aren’t yet available. A small open-label study found that a capsule containing 10 mg THC and 5 mg CBN improved subjective sleep quality, though it’s difficult to separate CBN’s contribution from THC’s well-established sedative effects.
The reputation may partly stem from the experience of smoking older cannabis, which is naturally higher in CBN. But aged cannabis also contains different terpene profiles and other degradation products that could contribute to a sedating feeling. The honest answer right now: CBN alone hasn’t been proven to help with sleep in controlled human studies.
Other Potential Therapeutic Effects
The most compelling research on CBN so far involves eye health. In laboratory and animal studies, CBN protected retinal cells from pressure-induced damage in a dose-dependent manner. It also reduced the buildup of structural proteins in the eye’s drainage tissue that contribute to increased eye pressure, a key driver of glaucoma. In a rat model of glaucoma, CBN lowered eye pressure and improved retinal function as measured by electroretinogram readings. These results are promising but still preclinical, meaning they haven’t been confirmed in human patients yet.
CBN has also shown anti-inflammatory properties in cell studies, which aligns with its CB2 receptor activity. Researchers have looked at its effects on pain and appetite stimulation as well, though human data remains extremely limited across the board.
CBN Products and Typical Doses
Consumer CBN products are widely available as oils, gummies, capsules, and tinctures. Most are marketed for sleep and relaxation. A common starting dose recommended by manufacturers is around 15 mg, and most commercial products contain between 5 and 30 mg per serving. One ongoing clinical trial (the “CUPID” study) is testing 30 mg and 300 mg doses in people with insomnia, with the lower dose chosen specifically to match what’s currently sold in the U.S. market.
It’s worth noting that these products are not FDA-approved for any medical condition. The FDA has preserved its authority to regulate all cannabis-derived products, including those from hemp, but has not evaluated CBN products for safety or effectiveness. Quality and accuracy of labeling can vary significantly between brands.
CBN Can Trigger a Positive Drug Test
If you’re subject to drug testing, this matters: CBN cross-reacts with at least two common urine immunoassay tests designed to detect THC metabolites. In lab testing, the EMIT II Plus assay required about five times more CBN than THC metabolite to trigger a positive result, while the Microgenics assay needed about 20 times more. CBN also showed an additive effect with any THC metabolite already present in the sample. So if you’re using CBN products (which may also contain trace amounts of THC), a positive screening result is a real possibility. Confirmatory testing can distinguish CBN from THC, but the initial screen may flag you.
Legal Status in the U.S.
CBN derived from hemp is federally legal under the 2018 Farm Bill, which removed hemp and all its cannabinoids, extracts, and derivatives from the Controlled Substances Act. The key condition is that the source plant must contain no more than 0.3% delta-9 THC on a dry weight basis. CBN derived from marijuana (cannabis with more than 0.3% THC) remains a controlled substance at the federal level.
State laws vary. Some states have restricted specific cannabinoids or placed additional regulations on hemp-derived products, so legality depends on where you live. The federal framework allows CBN products to be sold, but they’re still subject to FDA oversight for safety and labeling, just like any other consumer product.